Remission of chronic inflammatory demyelinating polyneuropathy after hepatitis C virus eradication with sofosbuvir and ledipasvir therapy

Muscle Nerve. 2018 Nov;58(5):E34-E36. doi: 10.1002/mus.26182. Epub 2018 Aug 30.

¹ Department of Neurology, Kansai Electric Power Hospital, Osaka, Japan.
² Department of Gastroenterology and Hepatology, Kansai Electric Power Hospital, Osaka, Japan.
³ Department of Neurology, Osaka City General Hospital, Osaka, Japan.

No abstract available

Keywords: CIDP; HCV; ledipasvir; sofosbuvir; sustained virological response.

Publication types

Antiviral Agents / adverse effects*
Benzimidazoles / adverse effects*
Fluorenes / adverse effects*
Hepacivirus / pathogenicity
Hepatitis C / complications
Hepatitis C / drug therapy*
Humans
Immunoglobulins, Intravenous / therapeutic use
Immunologic Factors / therapeutic use
Male
Middle Aged
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / chemically induced*
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / complications
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy
Recurrence
Sofosbuvir / adverse effects*